{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:10:27Z","timestamp":1762866627861},"reference-count":32,"publisher":"Frontiers Media SA","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":75,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/tri.12605","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T13:03:10Z","timestamp":1431435790000},"page":"1251-1264","source":"Crossref","is-referenced-by-count":28,"title":["Does belatacept improve outcomes for kidney transplant recipients? A systematic review"],"prefix":"10.3389","volume":"28","author":[{"given":"Nishanthi","family":"Talawila","sequence":"first","affiliation":[{"name":"Centre for Evidence in Transplantation; Clinical Effectiveness Unit; Royal College of Surgeons of England and the London School of Hygiene and Tropical Medicine; University of London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liset H. M.","family":"Pengel","sequence":"additional","affiliation":[{"name":"Centre for Evidence in Transplantation; Clinical Effectiveness Unit; Royal College of Surgeons of England and the London School of Hygiene and Tropical Medicine; University of London; London UK"},{"name":"Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,6,18]]},"reference":[{"key":"10.1111\/tri.12605-BIB0001|tri12605-cit-0001","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0002|tri12605-cit-0002","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0003|tri12605-cit-0003","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2215\/CJN.05081107","article-title":"Management of cardiovascular disease in renal transplant recipients","volume":"3","author":"Shirali","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12605-BIB0004|tri12605-cit-0004","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1600-6143.2005.01064.x","article-title":"Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation","volume":"5","author":"Hamdy","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0005|tri12605-cit-0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12605-BIB0006|tri12605-cit-0006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0007|tri12605-cit-0007","unstructured":"Nulojix (belatacept) prescribing information 2014 http:\/\/packageinserts.bms.com\/pi\/pi_nulojix.pdf"},{"key":"10.1111\/tri.12605-BIB0008|tri12605-cit-0008","first-page":"314","volume-title":"Kidney Transplantation: Principles and Practice","author":"Sayed","year":"2013","edition":"7"},{"key":"10.1111\/tri.12605-BIB0009|tri12605-cit-0009","first-page":"65","article-title":"Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients","volume":"3","author":"Martin","year":"2011","journal-title":"Transplant Risk Manag"},{"key":"10.1111\/tri.12605-BIB0010|tri12605-cit-0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1345\/aph.1Q537","article-title":"Belatacept: a new biologic and its role in kidney transplantation","volume":"46","author":"Su","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1111\/tri.12605-BIB0011|tri12605-cit-0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (benefit-ext study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0012|tri12605-cit-0012","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0013|tri12605-cit-0013","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2215\/CJN.05840710","article-title":"Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study","volume":"6","author":"Rostaing","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12605-BIB0014|tri12605-cit-0014","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (benefit study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0015|tri12605-cit-0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation blockade with belatacept in renal transplantation","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12605-BIB0016|tri12605-cit-0016","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/tri.12605-BIB0017|tri12605-cit-0017","first-page":"310","volume-title":"Cochrane Book Series","author":"Sterne","year":"2009"},{"key":"10.1111\/tri.12605-BIB0018|tri12605-cit-0018","unstructured":"Newell K Mannon R Mehta A et\u00a0al Long-Term Calcineurin Inhibitor (CNI) and Corticosteroid (CS) Avoidance Using Belatacept: The CTOT-10 Experience [abstract]"},{"key":"10.1111\/tri.12605-BIB0019|tri12605-cit-0019","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0020|tri12605-cit-0020","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1111\/ajt.12459","article-title":"Long-term exposure to belatacept in recipients of extended criteria donor kidneys","volume":"13","author":"Charpentier","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0021|tri12605-cit-0021","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","article-title":"Five-year safety and efficacy of belatacept in renal transplantation","volume":"21","author":"Vincenti","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12605-BIB0022|tri12605-cit-0022","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0b013e3181ff87cd","article-title":"Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies","volume":"12","author":"Larsen","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12605-BIB0023|tri12605-cit-0023","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1432-2277.2012.01535.x","article-title":"Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study","volume":"25","author":"Grinyo","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12605-BIB0024|tri12605-cit-0024","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/TP.0000000000000159","article-title":"Beneficial effect of belatacept on health-related quality of life and perceived side effects: results from the BENEFIT and BENEFIT-EXT trials","volume":"98","author":"Dobbels","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.12605-BIB0025|tri12605-cit-0025","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/01.ASN.0000070621.06264.86","article-title":"The change in allograft function among long-term kidney transplant recipients","volume":"14","author":"Gill","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12605-BIB0026|tri12605-cit-0026","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.TP.0000061602.03327.E2","article-title":"Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/tri.12605-BIB0027|tri12605-cit-0027","first-page":"472","volume-title":"Kidney Transplantation: Principles and Practice","author":"McQuarrie","year":"2013","edition":"7"},{"issue":"Suppl. 4","key":"10.1111\/tri.12605-BIB0028|tri12605-cit-0028","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-6143.2009.02898.x","article-title":"Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients","volume":"9","author":"Allen","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0029|tri12605-cit-0029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-6143.2011.03976.x","article-title":"Summary of the US FDA approval of belatacept","volume":"12","author":"Archdeacon","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12605-BIB0030|tri12605-cit-0030","unstructured":"Therapeutic Class Review. Immunosuppressants: Kidney Transplant - Focus on:belatacept (Nulojix) 2011 http:\/\/www.regencerx.com\/docs\/physicianRx\/immunosuppressants-nulojix-1011.pdf"},{"key":"10.1111\/tri.12605-BIB0031|tri12605-cit-0031","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/TP.0b013e31822a79ad","article-title":"A multicenter experience with generic tacrolimus conversion","volume":"92","author":"McDevitt-Potter","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/tri.12605-BIB0032|tri12605-cit-0032","unstructured":"Bristol Myer Squibb. Subcutaneous Pharmacokinetics Study 2007 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00569803"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12605","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12605\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:38:17Z","timestamp":1641062297000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,18]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12605","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,18]]}}}